https://www.dermatologytimes.com/view/how-mohs-surgeons-use-prognostic-testing-for-high-risk-scc
0
0
10/22/22 at 7:07pm
Organization
Dermatologytimes.com
40 words
0
Comments
The 40-gene expression profile (40-GEP) test can focus treatment options and optimize patient outcomes, according to a poster presentation at the 2022 Fall Clinical Dermatology Conference.
You are the first to view
Create an account
or login to join the discussion